Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (209 ops.)
Latest filing published 26 Jan 2026 for Vertex Pharmaceuticals INC / MA.
Filing timeline
BuySaleDavid Altshuler
First 200 filings with a declared amount
Insider track record
Disclosed buys
0
Disclosed sells
209
Signal history
David Altshuler: trading record in brief
209 sales worth EUR 78.5 million (EUR 78,518,680), median EUR 137,240: David Altshuler, EVP, Global Research and CSO of Vertex Pharmaceuticals INC / MA, sells often and in small lines. The three largest: EUR 4,549,841 on June 29, 2018, EUR 4,047,051 on July 19, 2017 and EUR 3,633,172 on July 16, 2018. No purchase.
Vertex Pharmaceuticals INC / MA is the only issuer in a record of 302 filings, from February 4, 2016 to January 26, 2026, with 49 grants and 44 option exercises. They are published a median of 2 days after the trade.
Annual volume peaks at 72 filings in 2020, ahead of 49 in 2022, 42 in 2018, 40 in 2019 and 33 in 2023; 2024 and 2025 fall back to 13 and 14. The last twelve months count 2 filings, with no purchase or sale.
Altshuler's sales track those of colleagues closely: 170 market trades fall within 30 days of a trade by Stuart A. Arbuckle, 133 of Amit Sachdev, 125 of Michael Parini and 120 of Ourania Tatsis, always in the same direction.
Companies and markets linked to David Altshuler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations302 total
3,328 shares0Common StockSEC:0000875320-26-000010:1
7,866 shares0Common StockSEC:0000875320-26-000010:0
52 shares@ US$424.690.1% of flowCommon StockSEC:0000875320-25-000201:0
3,231 shares@ US$510.004.6% of flowCommon StockSEC:0000875320-25-000152:0
3,231 shares@ US$500.004.5% of flowCommon StockSEC:0000875320-25-000144:0
3,231 shares@ US$490.004.6% of flowCommon StockSEC:0000875320-25-000139:0
1,272 shares@ US$480.000.5% of flowCommon StockSEC:0000875320-25-000120:1
5,954 shares@ US$479.618.3% of flowCommon StockSEC:0000875320-25-000120:0
3,971 shares@ US$483.285.6% of flowCommon StockSEC:0000875320-25-000101:0
848 shares@ US$480.950.3% of flowCommon StockSEC:0000875320-25-000101:1
1,111 shares@ US$480.001.6% of flowCommon StockSEC:0000875320-25-000099:0
2,293 shares@ US$463.463.1% of flowCommon StockSEC:0000875320-25-000077:0
5,324 shares0Common StockSEC:0000875320-25-000055:0
2,142 shares@ US$467.983.0% of flowCommon StockSEC:0000875320-25-000031:0
7,114 shares0Common StockSEC:0000875320-25-000005:1
12,314 shares0Common StockSEC:0000875320-25-000005:0
15 shares@ US$478.560.0% of flowCommon StockSEC:0000875320-24-000229:0
54 shares@ US$430.930.1% of flowCommon StockSEC:0000875320-24-000150:0
4,239 shares@ US$425.705.1% of flowCommon StockSEC:0000875320-24-000095:1
3,970 shares@ US$431.794.8% of flowCommon StockSEC:0000875320-24-000095:0
3,002 shares@ US$421.773.6% of flowCommon StockSEC:0000875320-24-000085:0
3,750 shares@ US$424.014.5% of flowCommon StockSEC:0000875320-24-000066:0
2,812 shares@ US$420.580.9% of flowCommon StockSEC:0000875320-24-000066:1
4,002 shares@ US$420.791.3% of flowCommon StockSEC:0000875320-24-000066:2
2,099 shares@ US$422.742.5% of flowCommon StockSEC:0000875320-24-000039:0
25 of 302 declarations
